PortfoliosLab logo

Ayala Pharmaceuticals, Inc. (AYLA)

Equity · Currency in USD · Last updated Nov 30, 2022

Company Info

ISINUS05465V1089
CUSIP05465V108
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.53
Year Range$0.53 - $9.75
EMA (50)$0.81
EMA (200)$2.76
Average Volume$202.03K
Market Capitalization$7.86M

AYLAShare Price Chart


Loading data...

AYLAPerformance

The chart shows the growth of $10,000 invested in Ayala Pharmaceuticals, Inc. in May 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $353 for a total return of roughly -96.47%. All prices are adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%JulyAugustSeptemberOctoberNovember
-68.23%
-5.25%
AYLA (Ayala Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AYLACompare to other instruments

Search for stocks, ETFs, and funds to compare with AYLA

Popular comparisons: AYLA vs. VOO

AYLAReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-23.17%1.45%
6M-65.13%-4.82%
YTD-93.77%-16.96%
1Y-94.62%-13.86%
5Y-72.93%12.47%
10Y-72.93%12.47%

AYLAMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-33.25%-30.11%0.25%-36.68%-29.76%-38.42%56.88%-4.09%-39.02%-24.00%-30.25%
202118.09%32.02%-36.38%-2.57%-10.25%6.81%22.67%1.36%-10.50%-3.17%-13.48%-10.42%
20200.33%-33.02%31.98%-11.10%-2.78%-1.13%-14.40%12.82%

AYLASharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Ayala Pharmaceuticals, Inc. Sharpe ratio is -0.69. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.20-1.00-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovember
-0.69
-0.63
AYLA (Ayala Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AYLADividend History


Ayala Pharmaceuticals, Inc. doesn't pay dividends

AYLADrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-97.59%
-17.49%
AYLA (Ayala Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AYLAWorst Drawdowns

The table below shows the maximum drawdowns of the Ayala Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Ayala Pharmaceuticals, Inc. is 97.61%, recorded on Nov 21, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.61%Feb 17, 2021446Nov 21, 2022
-44.72%May 19, 202077Sep 4, 2020109Feb 11, 2021186
-0.99%May 12, 20201May 12, 20204May 18, 20205

AYLAVolatility Chart

Current Ayala Pharmaceuticals, Inc. volatility is 98.20%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%JulyAugustSeptemberOctoberNovember
98.20%
13.39%
AYLA (Ayala Pharmaceuticals, Inc.)
Benchmark (^GSPC)